0001209191-17-045856.txt : 20170720
0001209191-17-045856.hdr.sgml : 20170720
20170720190033
ACCESSION NUMBER: 0001209191-17-045856
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170718
FILED AS OF DATE: 20170720
DATE AS OF CHANGE: 20170720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fu Tao
CENTRAL INDEX KEY: 0001644888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35935
FILM NUMBER: 17975287
MAIL ADDRESS:
STREET 1: 3175 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PORTOLA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001269021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 EAST GRAND AVENUE, SUITE 22
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-244-6864
MAIL ADDRESS:
STREET 1: 270 EAST GRAND AVENUE, SUITE 22
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-18
0
0001269021
PORTOLA PHARMACEUTICALS INC
PTLA
0001644888
Fu Tao
C/O PORTOLA PHARMACEUTICALS, INC.
270 GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, CBO
Common Stock
2017-07-18
4
M
0
5812
33.49
A
5812
D
Common Stock
2017-07-18
4
S
0
5812
65.00
D
0
D
Stock Option (Right to Buy)
33.49
2017-07-18
4
M
0
5812
0.00
D
2016-01-27
2026-01-27
Common Stock
5812
2917
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
/s/ Mike Ouimette, as attorney-in-fact
2017-07-20